What does this video actually claim?
@honestlyjayme shares her second week on Mounjaro (tirzepatide) and expresses disappointment with her weight loss results so far. She doesn't share specific numbers or make medical claims, just documents her personal experience with the medication.
The video is refreshingly honest about expectations versus reality. Many people starting GLP-1 medications expect dramatic results immediately, but the research tells a different story about realistic timelines.
Is week 2 disappointment normal with tirzepatide?
Yes, and anyone expecting significant weight loss by week 2 needs a reality check. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed that meaningful weight loss with tirzepatide takes months, not weeks.
Patients typically start at 2.5mg weekly and increase every 4 weeks. At this low starting dose, you're nowhere near the therapeutic range for weight loss. The study found that participants lost an average of 15% to 20.9% of body weight, but this was measured at 72 weeks, not 2 weeks.
Most people see minimal weight loss in the first month. The medication needs time to build up in your system and for the dose to reach effective levels.
What timeline should people actually expect?
Real weight loss with tirzepatide typically begins around week 4 to 8, once patients reach higher doses. The SURMOUNT-1 data shows the steepest weight loss occurred between weeks 12 and 36.
At the maximum 15mg dose, participants lost an average of 20.9% of their starting weight over 72 weeks. That's substantial, but it's not happening in your first two weeks on the starting dose.
Setting realistic expectations matters. People who expect rapid results often discontinue treatment prematurely, missing out on the medication's actual benefits.
Does @honestlyjayme get anything wrong?
She doesn't make any specific medical claims to fact-check, which is actually smart. Her disappointment is understandable but reflects unrealistic expectations that are common with GLP-1 medications.
The video could benefit from acknowledging that week 2 results aren't meaningful indicators of long-term success. Many viewers might interpret her disappointment as evidence that the medication doesn't work, when the science shows otherwise.
Her honesty about the experience is valuable, but context about normal timelines would help her audience set appropriate expectations.
What should people know about tirzepatide timing?
Tirzepatide works by activating GLP-1 and GIP receptors, slowing gastric emptying and reducing appetite. These effects build gradually as your dose increases over several months.
The medication follows a specific escalation schedule: 2.5mg for 4 weeks, then 5mg for 4 weeks, potentially increasing to 7.5mg, 10mg, 12.5mg, or 15mg based on tolerance and results. You can't judge effectiveness until you've been on a therapeutic dose for at least 8 to 12 weeks.
Insurance requirements often mandate 12-week trials before coverage decisions, which matches the clinical timeline for seeing meaningful results.